Demoxiclave Suspension

Amoxicillin Trihydrate USP with Clavulanic Acid USP

Composition : Amoxycillin USP + clavulanic acid USP (125mg+31.25mg/5ml) suspension.

Indications : Demoxiclave is indicated for shortterm treatment of bacterial infections at the following sites : Upper respiratory tract infections (including ENT) e.g. tonsillitis, sinusitis, otitis media. Lower respiratory tract infections e.g. acute and chronic bronchitis, lobar and bronchopneumonia. Genito-urinary tract infections e.g. cystitis, urethritis, pyelonephritis.

Skin and soft tissue infections. Bone and joint infections e.g. osteomyelitis.Other infections e.g. septic abortion, puerperal sepsis, intra-abdominal sepsis, etc.

Dosage & administration : Adults : 1 Demoxiclave-625 tablet every 12 hours or 1 Demoxiclave-375 tablet every 8 hours.

For more severe infections and infections of the respiratory tract 1 Demoxiclave-625 tablet every 8 hours. Demoxiclave is administered at the start of a meal. Children over 6 to 12 years : 2 teaspoonfuls of Demoxiclave oral suspension every 8 hours.

Children over 1 to 6 years : 1 teaspoonful of Demoxiclave oral suspension every 8 hours. Children below 1 year : 25 mg/kg/day in divided doses every 8 hours. Treatment should not be extended beyond 14 days without review.

Use in pregnancy and lactation : Demoxiclave has been assigned to pregnancy category B by the FDA.

Packing :

Demoxiclave suspension : 100ml oral suspension

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2022 Designed and Developed by ATI Limited.